CORPORATE INFO FOR INVESTORS OUR PRODUCTS BUSINESS DEVELOPMENT CONTACT US HOME

Menu

Financial Statements
  • Financial Reports
  • Securities Filing
      
    Investor Resources
  • Fact Sheet
  • Presentations
  • Analyst Coverage
  • Calendar of Events
  • FAQ
  • Shareholder
         Services
  • Investor Kit
  • Investor Information

    News
  • Press Releases
  • Corporate News
  • Awards
    •   PRESS RELEASES  
    COMMUNIQUÉS DE PRESSE (Français)

    2009  |   2008  |   2007  |   2006  |   2005  |   2004  |   2003  |   2002  |   2001  |   2000  |   1999  |   1998  |   1997  |  


    March 3, 2010
    PALADIN AND SPEPHARM ANNOUNCE NEW STRATEGIC RELATIONSHIP AND FINANCING
    (Also in PDF format)
    March 1, 2010
    PALADIN ANNOUNCES NORMAL COURSE ISSUER BID AND AUTOMATIC SHARE PURCHASE PLAN
    (Also in PDF format)
    February 25, 2010
    BTG AND PALADIN COMPLETE AGREEMENT FOR DIGIFAB FOR THE TREATMENT OF DIGOXIN TOXICITY
    (Also in PDF format)
    February 25, 2010
    PALADIN REPORTS FOURTEENTH CONSECUTIVE YEAR OF RECORD REVENUES
    (Also in PDF format)
    February 23, 2010
    PALADIN TO PRESENT AT THE RBC CAPITAL MARKETS HEALTHCARE CONFERENCE IN NEW YORK CITY
    (Also in PDF format)
    February 18, 2010
    NOTICE OF PALADIN LABS' 2009 FOURTH QUARTER RESULTS CONFERENCE CALL
    (Also in PDF format)
    February 18, 2010
    PALADIN LABS ANNOUNCES AMENDMENT TO R&D AGREEMENT WITH ISOTECHNIKA PHARMA INC.
    (Also in PDF format)
    February 4, 2010
    PALADIN GRANTED PRIORITY REVIEW STATUS FOR ABSTRAL(R) BY HEALTH CANADA
    (Also in PDF format)




    HOME | SITE MAP | LEGAL DISCLAIMER